T2 Biosystems Inc (TTOO)
3.695
+0.50
(+15.83%)
USD |
NASDAQ |
May 10, 16:00
3.695
0.00 (0.00%)
After-Hours: 19:39
T2 Biosystems Research and Development Expense (Quarterly): 3.169M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.169M |
September 30, 2023 | 2.663M |
June 30, 2023 | 3.85M |
March 31, 2023 | 4.471M |
December 31, 2022 | 4.659M |
September 30, 2022 | 6.375M |
June 30, 2022 | 8.025M |
March 31, 2022 | 6.656M |
December 31, 2021 | 5.353M |
September 30, 2021 | 6.384M |
June 30, 2021 | 5.399M |
March 31, 2021 | 4.665M |
December 31, 2020 | 3.764M |
September 30, 2020 | 3.782M |
June 30, 2020 | 3.786M |
March 31, 2020 | 4.78M |
December 31, 2019 | 4.279M |
September 30, 2019 | 4.098M |
June 30, 2019 | 4.048M |
March 31, 2019 | 3.901M |
December 31, 2018 | 3.296M |
September 30, 2018 | 2.725M |
Date | Value |
---|---|
June 30, 2018 | 3.749M |
March 31, 2018 | 4.718M |
December 31, 2017 | 4.156M |
September 30, 2017 | 5.88M |
June 30, 2017 | 7.112M |
March 31, 2017 | 6.585M |
December 31, 2016 | 5.849M |
September 30, 2016 | 5.20M |
June 30, 2016 | 6.369M |
March 31, 2016 | 6.589M |
December 31, 2015 | 6.638M |
September 30, 2015 | 6.204M |
June 30, 2015 | 6.651M |
March 31, 2015 | 5.868M |
December 31, 2014 | 5.21M |
September 30, 2014 | 4.803M |
June 30, 2014 | 4.703M |
March 31, 2014 | 5.065M |
December 31, 2013 | 4.29M |
September 30, 2013 | 3.358M |
June 30, 2013 | 3.727M |
March 31, 2013 | 3.561M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.663M
Minimum
Sep 2023
8.025M
Maximum
Jun 2022
4.748M
Average
4.471M
Median
Mar 2023
Research and Development Expense (Quarterly) Benchmarks
Abeona Therapeutics Inc | 7.379M |
Pacific Biosciences of California Inc | 44.54M |
INVO Bioscience Inc | 0.0059M |
Sensus Healthcare Inc | 0.677M |
Assure Holdings Corp | -- |